UBS Group’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-29,006
| Closed | -$784K | – | 10346 |
|
|
2024
Q2 | $784K | Sell |
29,006
-27,175
| -48% | -$565K | ﹤0.01% | 4641 |
|
|
2024
Q1 | $1.03M | Buy |
56,181
+35,275
| +169% | +$560K | ﹤0.01% | 4577 |
|
|
2023
Q4 | $257K | Buy |
20,906
+14,648
| +234% | +$137K | ﹤0.01% | 5612 |
|
|
2023
Q3 | $93.8K | Sell |
6,258
-5,292
| -46% | -$110K | ﹤0.01% | 5871 |
|
|
2023
Q2 | $375K | Buy |
11,550
+424
| +4% | +$15.5K | ﹤0.01% | 5058 |
|
|
2023
Q1 | $435K | Buy |
11,126
+7,352
| +195% | +$360K | ﹤0.01% | 4799 |
|
|
2022
Q4 | $199K | Buy |
3,774
+3,083
| +446% | +$150K | ﹤0.01% | 5449 |
|
|
2022
Q3 | $31K | Sell |
691
-104
| -13% | -$4.47K | ﹤0.01% | 6849 |
|
|
2022
Q2 | $29K | Sell |
795
-168
| -17% | -$6.1K | ﹤0.01% | 6447 |
|
|
2022
Q1 | $40K | Sell |
963
-991
| -51% | -$34.9K | ﹤0.01% | 6713 |
|
|
2021
Q4 | $83K | Buy |
1,954
+1,032
| +112% | +$51.6K | ﹤0.01% | 6476 |
|
|
2021
Q3 | $51K | Sell |
922
-121
| -12% | -$6.33K | ﹤0.01% | 6316 |
|
|
2021
Q2 | $50K | Sell |
1,043
-809
| -44% | -$41.2K | ﹤0.01% | 6435 |
|
|
2021
Q1 | $94K | Sell |
1,852
-452
| -20% | -$25.1K | ﹤0.01% | 6018 |
|
|
2020
Q4 | $145K | Sell |
2,304
-4,461
| -66% | -$277K | ﹤0.01% | 5454 |
|
|
2020
Q3 | $455K | Buy |
6,765
+208
| +3% | +$11.4K | ﹤0.01% | 4271 |
|
|
2020
Q2 | $275K | Buy |
6,557
+57
| +0.9% | +$2.19K | ﹤0.01% | 4579 |
|
|
2020
Q1 | $205K | Sell |
6,500
-2,887
| -31% | -$116K | ﹤0.01% | 4707 |
|
|
2019
Q4 | $380K | Buy |
9,387
+9,032
| +2,544% | +$316K | ﹤0.01% | 5083 |
|
|
2019
Q3 | $292K | Sell |
355
-1,117
| -76% | -$44.5K | ﹤0.01% | 4967 |
|
|
2019
Q2 | $72K | Buy |
+1,472
| New | +$62.6K | ﹤0.01% | 5623 |
|
Other funds holding SILK
UBS Group's SILK Position: Q3 2024 in Review
UBS Group sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 29,006 shares — an estimated $784K sold.
UBS Group first reported a position in SILK in Q2 2019 and held it in 21 quarters. The position peaked at $1.03M in Q1 2024. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.
- UBS Group reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
- UBS Group sold 29,006 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $784K.
- UBS Group first reported a position in Silk Road Medical, Inc. Common Stock in Q2 2019 and held it in 21 quarters.
- UBS Group's Silk Road Medical, Inc. Common Stock position peaked at $1.03M in Q1 2024.
- 1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.
Based on UBS Group's 13F filing for Q3 2024, filed 14 Nov 2024.